Description: The Seed Investment package is designed for smaller investors or those looking to make a modest initial investment in Halo Pharms. It provides an opportunity to participate in the company's growth while offering basic ownership stakes with lower minimum investment requirements.

Key Features:

1. Investment Structure: Revenue Sharing Agreement (RSA).
   
2. Ownership Stake: Investors receive a revenue-sharing arrangement rather than direct equity ownership, ensuring that total investor ownership remains within the desired range of 30% to 35%.
3. Investment Threshold: The minimum investment for the Seed Investment package is set at $50,000, making it accessible to a broader range of investors.
   
4. Profit Sharing: Investors are entitled to a portion of Halo Pharms' revenue as outlined in the revenue-sharing agreement. The profit share is distributed proportionally based on the investment amount.
   
5. Voting Rights: As the majority owner, Halo Pharms retains full control over voting rights, ensuring that key decisions are made in accordance with the company's vision and strategy.
   
6. Strategic Direction: Investors in the Seed Investment package do not have the authority to dictate the specific strains grown by the company or influence day-to-day operations. However, they may receive regular updates on company progress and performance.
   
7. Alignment of Interests: The Seed Investment package aligns investor interests with those of Halo Pharms by providing an opportunity to share in the company's success while maintaining control over strategic decision-making.

Benefits:

• Lower barrier to entry: The Seed Investment package offers a lower minimum investment threshold, allowing smaller investors to participate in Halo Pharms' growth.
  
• Revenue-based returns: Investors receive a share of the company's revenue, providing a potential source of income while minimizing dilution of ownership.
  
• Limited involvement: Investors can support Halo Pharms' growth without the need for active involvement in day-to-day operations or decision-making processes.

This Starter Package aims to cater to smaller investors or those looking for a modest initial investment opportunity in Halo Pharms, while also aligning with the company's strategic objectives and ownership structure preferences.

Description: The Growth Investment package caters to investors seeking a moderate level of involvement and return in Halo Pharms. It offers a balanced approach between investment amount, potential returns, and associated rights or benefits.

Key Features:

1. Investment Structure: Convertible Note or Preferred Stock
   
2. Ownership Stake: Investors receive direct equity ownership in Halo Pharms through convertible notes or preferred stock, ensuring a stake in the company's growth while maintaining investor ownership within the desired range of 30% to 35%.
3. Investment Threshold: The minimum investment for the Growth Investment package is set at $100,000, offering a moderate entry point for investors seeking meaningful involvement.
   
4. Profit Sharing: Investors are entitled to a share of Halo Pharms' profits proportional to their ownership stake. Dividends or distributions may be paid out periodically based on company performance.
   
5. Voting Rights: As the majority owner, Halo Pharms retains majority control over voting rights, ensuring that key decisions are made in alignment with the company's strategic vision.
   
6. Strategic Direction: While investors have a voice in major strategic decisions through voting rights, day-to-day operations and strain selection remain under the control of Halo Pharms' management team.
   
7. Alignment of Interests: The Growth Investment package aligns investor interests with those of Halo Pharms by providing a stake in the company's success and growth trajectory.

Benefits:

• Direct equity ownership: Investors receive direct ownership stakes in Halo Pharms, allowing them to participate in the company's growth and potential appreciation in value.
  
• Potential for dividends: Investors may receive dividends or distributions based on the company's profitability, providing a potential source of income in addition to capital appreciation.
  
• Moderate involvement: Investors have a voice in strategic decisions through voting rights, while leaving day-to-day operations to the company's management team.

Description: The Elite Investment package targets larger investors or those seeking enhanced benefits and privileges in Halo Pharms. It offers preferential treatment in terms of profit sharing, voting rights, or access to exclusive opportunities within the company.

Key Features:

1. Investment Structure: Equity with Preferential Terms
   
2. Ownership Stake: Investors receive direct equity ownership in Halo Pharms with preferential terms, ensuring a significant stake in the company's success while maintaining total investor ownership within the desired range of 30% to 35%.
3. Investment Threshold: The minimum investment for the Elite Investment package is set at $250,000, attracting larger investors seeking enhanced benefits and privileges.
   
4. Profit Sharing: Investors receive preferential treatment in profit sharing, potentially entitling them to higher dividends or distributions compared to standard equity investors.
   
5. Voting Rights: As the majority owner, Halo Pharms retains majority control over voting rights. However, premium investors may receive enhanced voting rights or representation on the company's board of directors.
   
6. Strategic Direction: Premium investors may have the opportunity to provide input on strategic initiatives and direction, with Halo Pharms considering their perspectives alongside its strategic objectives.
   
7. Alignment of Interests: Premium investors may receive access to exclusive opportunities within Halo Pharms, such as early access to new products or technologies, VIP events, or personalized investor relations support.

Benefits:

• Preferential treatment: Premium investors receive enhanced benefits and privileges, including preferential profit sharing, voting rights, and access to exclusive opportunities within Halo Pharms.
  
• Strategic influence: Premium investors have the opportunity to provide input on strategic direction and initiatives, potentially shaping the future growth and success of the company.
  
• Exclusive opportunities: Premium investors receive access to exclusive opportunities and experiences within Halo Pharms, enhancing their investment experience and engagement with the company.

These packages cater to investors with varying levels of investment capacity and preferences, offering tailored options to suit their needs and objectives while aligning with Halo Pharms' strategic goals and ownership structure.

Description: Halo Pharms offers customized investment packages tailored to the specific needs and preferences of individual or institutional investors. These packages provide flexibility to negotiate unique terms, conditions, and benefits based on mutual agreements between the company and the investor.

Key Features:

1. Customization Options: Investors have the opportunity to customize their investment packages based on their investment objectives, risk tolerance, and desired level of involvement in Halo Pharms.
2. Investment Structure: Various investment structures are available, including equity, debt, revenue sharing, or hybrid instruments, allowing investors to choose the most suitable option for their needs.
3. Ownership Stake: Investors can negotiate the desired ownership stake in Halo Pharms, ensuring alignment with their investment goals while respecting the company's ownership structure preferences (30% to 35% investor ownership opportunity).
4. Investment Threshold: Customized investment packages cater to investors with varying investment capacities, allowing for flexible minimum investment thresholds based on individual circumstances.
5. Profit Sharing: Investors have the opportunity to negotiate profit-sharing arrangements tailored to their preferences, including revenue-based returns, dividends, or other distribution mechanisms.
6. Voting Rights: Halo Pharms works with investors to determine voting rights and governance structures that align with the company's strategic objectives while respecting investor preferences and influence.
   
7. Strategic Direction: Customized packages may include provisions for investor involvement in strategic decision-making processes, such as board representation, advisory roles, or input on key initiatives.
8. Additional Benefits: Investors may negotiate additional benefits or privileges tailored to their needs, such as access to exclusive opportunities, preferential treatment, or personalized investor relations support.

Benefits:

• Tailored solutions: Customized investment packages allow investors to tailor their investment to their specific preferences, objectives, and requirements.
  
• Flexibility: Investors have the flexibility to negotiate terms, conditions, and benefits that best suit their needs, ensuring a mutually beneficial arrangement with Halo Pharms.
  
• Strategic alignment: Customized packages foster alignment between investors and Halo Pharms, enabling collaboration and cooperation towards shared goals and objectives

Note: Customized packages are designed to accommodate the diverse needs and preferences of investors, offering flexibility and personalized solutions to maximize value and mutual benefit. The terms, conditions, and benefits of each package are subject to negotiation and agreement between Halo Pharms and the investor.

Description: Halo Pharms offers specialized investment funds or programs tailored to specific industries, technologies, or market segments. These funds or programs attract investors with a particular interest or expertise in those areas and provide investment opportunities aligned with their preferences and objectives.

Key Features:

1. Targeted Focus: Specialized funds or programs focus on specific industries, technologies, or market segments where Halo Pharms sees strategic opportunities for growth and innovation.
2. Investment Structure: Various investment structures are available within specialized funds or programs, including equity, debt, revenue sharing, or hybrid instruments, tailored to the unique characteristics of the targeted sector.
   
3. Investment Strategy: Halo Pharms develops investment strategies within specialized funds or programs that leverage its expertise and insights into the targeted industry or market segment, maximizing potential returns for investors.
4. Investor Criteria: Specialized funds or programs attract investors with a particular interest or expertise in the targeted area, ensuring alignment between investor preferences and the investment focus.
5. Diversification: Investors benefit from diversification within specialized funds or programs, gaining exposure to a range of opportunities within the targeted sector while mitigating risk through portfolio diversification.
6. Customization Options: Investors may have the opportunity to customize their investment within specialized funds or programs based on their specific preferences, risk tolerance, and investment objectives.
7. Management Expertise: Halo Pharms' management team possesses specialized expertise and experience in the targeted industry or market segment, providing investors with confidence in the fund's ability to deliver value and achieve strategic objectives.

Benefits:

• Strategic alignment: Specialized funds or programs align with investors' interests and expertise, offering targeted investment opportunities that match their preferences and objectives.
  
• Access to expertise: Investors benefit from Halo Pharms' specialized knowledge and insights into the targeted industry or market segment, enhancing the quality of investment decisions and potential returns.
  
• Diversification: Specialized funds or programs provide investors with diversification benefits, reducing risk exposure and enhancing portfolio performance through exposure to multiple opportunities within the targeted sector.

Note: Specialized funds or programs are designed to capitalize on strategic opportunities within specific industries, technologies, or market segments, providing targeted investment solutions that align with investor preferences and objectives. The structure, strategy, and benefits of each fund or program are tailored to the unique characteristics of the targeted sector and the needs of investors.

1. Fundraising Round:
   • The Seed Round for Halo Pharms commences on May 1, 2024, and concludes on August 31, 2024.
   • During this period, investors have the opportunity to participate in the Seed Round by committing capital to support Halo Pharms' growth and development initiatives.
2. Minimum Investment Thresholds:
   • Equity Investors interested in participating in the Seed Investment package must commit to a minimum investment of $50,000.
   • For investors considering the Growth Investment package, the minimum investment requirement is set at $100,000.
   • The Elite Investment package requires a minimum investment of $250,000 for participation.
3. Eligibility Criteria:
   • Investors interested in participating in the Seed Round must meet certain eligibility criteria, including accreditation status, compliance with regulatory requirements, and adherence to Halo Pharms' investment guidelines.
   • Halo Pharms reserves the right to verify the eligibility of investors and may request documentation or information to confirm compliance with eligibility criteria.
4. Participation Process:
   • Interested investors must express their intent to participate in the Seed Round by submitting a formal investment commitment to Halo Pharms (investors@halopharms.com).
   • Investment commitments must be submitted within the designated timeframe of the Seed Round, between May 1, 2024, and August 31, 2024.
   • Investors must indicate their preferred investment package (Seed, Growth, or Elite) and ensure that their investment amount meets the minimum threshold for the selected package.
5. Investment Terms:
   • Investors participating in the Seed Round agree to the investment terms and conditions outlined in the respective investment packages (Seed, Growth, or Elite).
   • The terms of each investment package, including profit-sharing arrangements, voting rights, and additional benefits, are detailed in the corresponding investment documentation provided by Halo Pharms.
6. Communication and Updates:
   • Halo Pharms maintains open communication with investors throughout the Seed Round, providing regular updates, progress reports, and any relevant information pertaining to the investment opportunity.
   • Investors may reach out to Halo Pharms' investor relations team for assistance, inquiries, or clarification regarding the Seed Round and investment process (investors@halopharms.com).
7. Disclaimer:
   • Halo Pharms reserves the right to modify or terminate the Seed Round at its discretion, including changes to investment terms, deadlines, or participation criteria.
   • Any modifications or updates to the Seed Round will be communicated to investors through official channels, ensuring transparency and compliance with applicable regulations.
8. Legal and Regulatory Compliance:
   • Halo Pharms conducts the Seed Round in compliance with relevant laws, regulations, and securities requirements governing private investments.
   • The company engages legal counsel and financial advisors to ensure that the Seed Round adheres to applicable legal and regulatory standards, protecting the interests of both investors and the company.

Note: The Terms and Conditions outlined above provide a framework for participating in the Seed Round at Halo Pharms, including eligibility criteria, investment thresholds, participation process, and legal compliance. Investors are encouraged to review all relevant documentation and seek professional advice before making investment decisions.